Consequently, disrupting the TACO1‐circFOXK2‐HSP90β complex inhibits cancer stemness and cisplatin resistance in BCa cells by suppressing the MTCO1/OXPHOS/mtROS axis. This evidence concerns the gene HSP90AB1 and cancer.